A versatile antibody capture system drives specific in vivo delivery of mRNA-loaded lipid nanoparticles
Top Cited Papers
Open Access
- 4 August 2025
- journal article
- Published by Springer Nature in Nature Nanotechnology
- Vol. 20 (9) , 1273-1284
Abstract
Efficient and precise delivery of mRNA is critical to advance mRNA therapies beyond their current use as vaccines. Lipid nanoparticles (LNPs) efficiently encapsulate and protect mRNA, but non-specific cellular uptake may lead to off-target delivery and minimal delivery to target cells. Functionalizing LNPs with antibodies enables targeted mRNA delivery, but traditional modification techniques require complex conjugation and purification, which often reduces antibody affinity. Here we present a simple method for capturing antibodies in their optimal orientation on LNPs, without antibody modification or complex purification. This strategy uses an optimally oriented anti-Fc nanobody on the LNP surface to capture antibodies, resulting in protein expression levels more than 1,000 times higher than non-targeted LNPs and more than 8 times higher than conventional antibody functionalization techniques. These precisely targeted LNPs showed highly efficient in vivo targeting to T cells, with minimal delivery to other immune cells. This approach enables the rapid development of targeted LNPs and has the potential to broaden the use of mRNA therapies.Keywords
Funding Information
- Department of Health | National Health and Medical Research Council (GNT2011963, GNT1141551)
- Victoria State Government through funding support from mRNA Victoria for the Victorian mRNA Innovation Hub
This publication has 48 references indexed in Scilit:
- Beyond the Endosomal Bottleneck: Understanding the Efficiency of mRNA/LNP DeliveryAdvanced Functional Materials, 2024
- UCSF ChimeraX : Tools for structure building and analysisProtein Science, 2023
- Delivery of Therapeutic RNA to the Bone Marrow in Multiple Myeloma Using CD38‐Targeted Lipid NanoparticlesAdvanced Science, 2023
- A Combinatorial Library of Lipid Nanoparticles for Cell Type‐Specific mRNA DeliveryAdvanced Science, 2023
- Therapeutic Gene Silencing Using Targeted Lipid Nanoparticles in Metastatic Ovarian CancerSmall, 2021
- Leukocyte-specific siRNA delivery revealing IRF8 as a potential anti-inflammatory targetJournal of Controlled Release, 2019
- Influence of particle size on the in vivo potency of lipid nanoparticle formulations of siRNAJournal of Controlled Release, 2016
- Improving immunobinding using oriented immobilization of an oxidized antibodyJournal of Chromatography A, 2007
- Prolegomena to Future Experimental Efforts on Genetic Code Engineering by Expanding Its Amino Acid RepertoireAngewandte Chemie International Edition, 2004
- Crystallographic structure of an intact IgG1 monoclonal antibody 1 1Edited by I. A. WilsonJournal of Molecular Biology, 1998